These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38493926)

  • 1. Prediction of MET Overexpression in Lung Adenocarcinoma from Hematoxylin and Eosin Images.
    Ingale K; Hong SH; Bell JSK; Rizvi A; Welch A; Sha L; Ho I; Nagpal K; Bentaieb A; Joshi RP; Stumpe MC
    Am J Pathol; 2024 Jun; 194(6):1020-1032. PubMed ID: 38493926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study.
    Wang N; Zhang Y; Wu J; Zhu Y; Wu Y; Huang B; Zhang R; Fan J; Nie X
    Clin Transl Oncol; 2024 Jul; 26(7):1696-1707. PubMed ID: 38430418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
    Chen Y; Tang J; Lu T; Liu F
    Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy.
    Hsieh MS; Lin MW; Lee YH
    Lung Cancer; 2019 Nov; 137():76-84. PubMed ID: 31561203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS-1 re-arrangements and c-MET amplifications in adenocarcinoma lung: A tertiary care center study from North India.
    Shukla S; Pandey RK; Kant S; Garg R; Husain N
    Indian J Pathol Microbiol; 2019; 62(3):433-436. PubMed ID: 31361233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer.
    Rączkowska A; Paśnik I; Kukiełka M; Nicoś M; Budzinska MA; Kucharczyk T; Szumiło J; Krawczyk P; Crosetto N; Szczurek E
    BMC Cancer; 2022 Sep; 22(1):1001. PubMed ID: 36131239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms.
    Mayer C; Ofek E; Fridrich DE; Molchanov Y; Yacobi R; Gazy I; Hayun I; Zalach J; Paz-Yaacov N; Barshack I
    Mod Pathol; 2022 Dec; 35(12):1882-1887. PubMed ID: 36057739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal-epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinoma.
    Ando R; Fujino M; Kominami-Kiriyama A; Ito A; Koide T; Ito M
    Jpn J Clin Oncol; 2019 Aug; 49(8):755-761. PubMed ID: 31329925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
    Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
    PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
    Guo R; Berry LD; Aisner DL; Sheren J; Boyle T; Bunn PA; Johnson BE; Kwiatkowski DJ; Drilon A; Sholl LM; Kris MG
    J Thorac Oncol; 2019 Sep; 14(9):1666-1671. PubMed ID: 31228623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform.
    Qi Z; Wang L; Desai K; Cogswell J; Stern M; Lawson B; Kerkar SP; Vitazka P
    J Mol Diagn; 2019 Sep; 21(5):796-807. PubMed ID: 31255795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein overexpression and gene amplification of cellular mesenchymal-epithelial transition factor is associated with poor prognosis in micropapillary-predominant subtype pulmonary adenocarcinoma.
    Zhang J; Sun J; Zhang Z; Liang X; Luo Y; Wu S; Liang Z
    Hum Pathol; 2018 Feb; 72():59-65. PubMed ID: 29128478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
    Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation analysis of mesenchymal-epithelial transition factor protein and human epidermal growth receptor 2 protein expression in 1479 cases of lung adenocarcinoma in China.
    Yang L; Che Y; Guo L; Zheng B; Wang B; Yang Z; Zhu Y; Li J
    Thorac Cancer; 2018 Apr; 9(4):439-444. PubMed ID: 29400000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
    Boyle TA; Khalil FK; Mino-Kenudson M; Sica GL; Moreira AL; Sholl LM; Knight MZ; Zhang L; Saller J; Varella-Garcia M; Berry LD; Chen H; Ellison KE; Rivard CJ; Kugler K; Wistuba II; Fujimoto J; Kwiatkowski DJ; Bunn PA; Kris MG; Haura EB; Hirsch FR;
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):669-677. PubMed ID: 31876606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of OPN3 in lung adenocarcinoma promotes epithelial-mesenchymal transition and tumor metastasis.
    Xu C; Wang R; Yang Y; Xu T; Li Y; Xu J; Jiang Z
    Thorac Cancer; 2020 Feb; 11(2):286-294. PubMed ID: 31802643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.